We soon realised that the market opportunities for OSCEAUN™ exist wherever pathogens are causing problems. This goes far beyond Human Health
We considered aspects that could be seen as hurdles to commercialisation and designed, formulations, manufacture methods, delivery techniques, and legislation requirements that allowed patenting and commercial protections. Now we are ready to declare our success to the world. The existing markets have been identified and all are desperate for a technology that offers a real chance to overcome the pathogens without causing collateral damage.
We will take steps, to protect, and ensure, our leadership of this new technology and to be able to take advantages offered by the technology. Our intentions is to establish the QURES ACADEMY
Click QURES ACADEMY to see how it will work
Sales and Marketing, and other actions by QURES for the promotion of OSCEAUN™ will vary for each application area and territory. It will be a combination of direct and indirect sales, together with licencing in one or more territories. We will seek guidance and support from industry experts and consultants to enter, or even withdraw, from various activities. We will also consider equity involvement from third parties in some applications or territories.
At all times, retention and protection of the IP and knowledge will be paramount in our decisions and relationships